Surgical Treatment for Early Germ Cell Tumors

  • E. C. Skinner
Part of the Medical Radiology book series (MEDRAD)


Germ cell cancer of the testis occurs in young men and is currently one of the most curable solid tumors in humans. The successful treatment of this disease requires a multidisciplinary approach, with close co-operation between the urologist, radiation oncologist, and medical oncologist.


Germ Cell Tumor Testicular Cancer Inferior Mesenteric Artery Left Renal Vein Retroperitoneal Lymph Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aass N, Fossa SD, Ous S, Lien HH, Stenwig AE, Paus E, Kaalhus O (1990) Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer? Br J Urol 65: 385–390PubMedCrossRefGoogle Scholar
  2. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP (1994) Complications of primary retroperitoneal lymph node dissection. J Urol 152: 424–427PubMedGoogle Scholar
  3. Bochner BH, Lerner SP, Kawachi M, Williams RD, Scardino PT, Skinner DG (1995) Post radical orchiectomy hemor-rhage: should an alteration in staging strategy for testicular cancer be considered? Urology 46: 408–411PubMedCrossRefGoogle Scholar
  4. Capelouto CC, Clark PE, Ransil BJ, Loughlin KR (1995) A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol 153: 981–985PubMedCrossRefGoogle Scholar
  5. Colleselli K, Poisel S, Schachtner W, Bartch G (1990) Nerve-preserving bilateral retroperitoneal lymphadenectomy: anatomical study and operative approach. J Urol 144: 293–298PubMedGoogle Scholar
  6. Doerr A, Skinner EC, Skinner DG (1993) Preservation of ejaculation through a modified retroperitoneal lymph node dissection in low stage testis cancer. J Urol 149: 1472–1474PubMedGoogle Scholar
  7. Donohue JP, Zachary JM, Maynard BR (1982) Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 128: 315–320PubMedGoogle Scholar
  8. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R (1993) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol 149: 237–243PubMedGoogle Scholar
  9. Donohue JP, Thornhill JA, Foster RS, Bihrle R, Rowland RG, Einhorn LH (1995) The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965–1989). J Urol 153: 85–89PubMedCrossRefGoogle Scholar
  10. Dunphy CH, Ayala AG, Swanson DA, Ro JY, Logothetis C (1988) Clinical stage I nonseminomatous and mixed germ cell tumors of the testis: a clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone. Cancer 62: 1202–1206PubMedCrossRefGoogle Scholar
  11. Foster RS, Baniel J, Leibovitch I, Curran M, Bihrle R, Rowland R, Donohue JP (1996) Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer. J Urol 155: 1943–1945PubMedCrossRefGoogle Scholar
  12. Freiha F, Torti F (1989) Orchiectomy only for clinical stage I non-seminomatous germ cell testis tumors. Comparison with pathologic stage I disease. Urology 34: 347–348Google Scholar
  13. Gelderman WAH, Koops HS, Sleijfer DT, Oosterhuis JW, Marrink J, de Bruijn HWA, Oldhoff J (1987) Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors. Cancer 578–580Google Scholar
  14. Gerber GS, Bissada NK, Hulbert JC, Kavoussi LR, Moore RG, Kantoff PW, Rukstalis DB (1994) Laparoscopic retroperitoneal lymphadenectomy: multi-institutional analysis. J Urol 152: 1188–191PubMedGoogle Scholar
  15. Jewett MAS, Kong Y-S, Goldberg SD, Sturgeon JFG, Thomas GM, Alison RE, Gospodarowicz MK (1988) Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139: 1220–1224PubMedGoogle Scholar
  16. Leibovitch I, Baniel J, Foster RS, Donohue JP (1995) The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer. J Urol 154: 935–939PubMedCrossRefGoogle Scholar
  17. Logothetis CJ, Samuels ML, Trindade A, Johnson DE (1982) The growing teratoma syndrome. Cancer 50: 1629–1635PubMedCrossRefGoogle Scholar
  18. Lowe BA (1993) Surveillance versus nerve-sparing retroperitoneal lymph node dissection in stage I nonseminomatous germ0cell tumors. Urol Clin North Am 20: 75–83PubMedGoogle Scholar
  19. Nicolai N, Pizzocaro G (1995) A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10 year followup. J Urol 154: 1045–1049PubMedCrossRefGoogle Scholar
  20. Richie JP (1990) Clinical stage I testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 144: 1160–1163PubMedGoogle Scholar
  21. Skinner DG, Melamud A, Lieskovsky G (1982) Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol 127: 1107–1110PubMedGoogle Scholar
  22. Stone NN, Schlussel RN, Waterhouse RL, Unver P (1993) Laparoscopic retroperitoneal lymph node dissection in stage A nonseminomatous testis cancer. Urology 42:610– 614Google Scholar
  23. Studer UE, Fey MF, Calderoni A, Kraft R, Mazzucchelli L, Sonntag RW (1993) Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. Eur Urol 23: 444–449PubMedGoogle Scholar
  24. Sturgeon JF, Jewett MA, Alison RE, et al. (1992) Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol 10: 564–568PubMedGoogle Scholar
  25. Wishnow KI, Johnson DE, Tenney DM, et al. (1989) Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance. Urology 34: 339–343PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • E. C. Skinner
    • 1
  1. 1.Department of UrologyUniversity of Southern California, Norris Comprehensive Cancer CenterLos AngelesUSA

Personalised recommendations